ZYDUSLIFE
Zydus Lifesciences Limited
Pharmaceuticals
Share price
₹1,120
Market cap
₹1.1L Cr
1Y return
▲ 12%
A vertically integrated pharmaceutical company, Zydus Lifesciences develops, manufactures, and markets generic drugs, specialty pharmaceuticals, and biologics for domestic and international markets. The company operates across multiple therapeutic areas including cardiology, gastroenterology, oncology, and immunology. It serves patients globally through its extensive distribution network, research capabilities, and commitment to addressing unmet healthcare needs across diverse populations and geographies.
Investors holding Zydus Lifesciences Limited
5.41%
Latest move
LICDecreased
LIC decreased its stake in Zydus Lifesciences from 5.56% to 5.41%, selling 19.37 lakh shares for ₹224.50 Cr at ₹1159.00 apiece.
Sign in to read more
Whales made 2 more moves in Zydus Lifesciences Limited
Sign in to see who is buying and selling.
Sign in to find out